Dr David Pettigrew

Chief Executive Officer

David leads the go to market strategy for my mhealth globally. He has 15 years of experience of digital health and medical device product development, and has taken a number of CE marked and 510k approved products to market in both the US and the EU. He was an early pioneer in integrating smartphone apps with implantable medical device systems, and has served on the leadership team of two global companies who develop digital health solutions for the pharma and medtech industry; Sagentia and BrightInsight. David has a DPhil in molecular biophysics from the University of Oxford.

Dr Simon Bourne

Non Executive Director

Dr Simon Bourne qualified as a doctor from University College London in 1995 and specialised in respiratory medicine. He took up the role as lead COPD consultant, and senior lecturer at University Hospital Southampton in 2007, where he took most of his practice from the hospital, into the community within the first 3 months.

Realising innovation was key to reaching his patients, and delivering quality care at scale, Simon set up new community pathways within Southampton City and later formed a digital health company, my mhealth Limited in 2012. Simon joined the first cohort of NHS Nation Innovation Fellows in 2015 and successfully achieved national procurement of myCOPD in 2015.

Simon is passionate about helping every patient get access to expert advice and interventions at a time and place that suits them. Simon successfully built on the success of myCOPD to build a co-morbidity platform for patients, and clinicians to manage Asthma, COPD, COVID-19, Diabetes and Heart Disease.

His next ambition is to build a next-generation AI engine into the products to enable the delivery of precision medicine at population scale.

Professor Tom Wilkinson

Chief Scientific Officer and Co-Founder
Professor & Honorary NHS Consultant Respiratory Medicine Southampton University Faculty of Medicine

Professor Tom Wilkinson is CSO of my mhealth, Professor of Respiratory Medicine at the University of Southampton, and Honorary Consultant at University Hospitals Southampton. He trained at the University of Cambridge and Barts and the London School of Medicine and completed his PhD at UCL studying disease mechanisms driving Infective Exacerbations of COPD. He has 20 years’ experience in health care innovation and health services research and in 2012 co-founded my mhealth with Simon Bourne. He is now a Director and Chief Scientific Officer for the company and leads the digital health research programme.

Tom’s research seeks to improve outcomes for patients with long-term conditions. He currently leads several large-scale programmes of digital health implementation and appraisal across the NHS. He and his team are developing data-driven models of disease to help patients and clinicians better understand the outcome and to optimise treatment. Working with thought leaders in AI and data science the my mhealth research team is now developing the next generation of digital therapeutics.

Tom has published over 100 peer-reviewed papers and reviews. His work has been recognised by National and International Awards including the European award for Innovation in Respiratory Medicine.

Paul Gaudin

Non Executive Director

Paul has been an entrepreneur and investor in Medtech and Insurtech for 28 years and sits on the board of directors.

Antony Walters BA(Hons) MBA FCA

Non Executive Director

Antony is a Chartered Accountant with an MBA from Warwick University. He has worked in the health sector for over twenty five years in various director level roles including as CEO, MD, CFO and Non-executive Director for companies such as Lloyds Pharmacy, Ashley House plc and Partnering Health Limited.

Through his company, Welland Advisory Limited, Antony advises a range of small and medium sized companies in areas such as financial management and strategy, corporate governance, legal and M&A. He is also a Non-executive Director for a not for profit Enterprise Agency.

Wendy Hall

Non Executive Director

Wendy is the General Counsel of AAH Pharmaceuticals Limited and represents one of our shareholders as an investor director. Wendy has worked in the health care sector for 15 years and has watched the business develop and grow to where it is now, and is excited to be involved in the next steps of our development.